These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. In Vitro and In Vivo Detection of Drug-induced Apoptosis Using Annexin V-conjugated Ultrasmall Superparamagnetic Iron Oxide (USPIO): A Pilot Study. Nishie A; Togao O; Tamura C; Yamato M; Ichikawa K; Nohara S; Ito Y; Kato N; Yoshise S; Honda H Magn Reson Med Sci; 2019 Apr; 18(2):142-149. PubMed ID: 30282879 [TBL] [Abstract][Full Text] [Related]
9. Direct coupling of annexin A5 to VSOP yields small, protein-covered nanoprobes for MR imaging of apoptosis. Figge L; Appler F; Chen HH; Sosnovik DE; Schnorr J; Seitz O; Taupitz M; Hamm B; Schellenberger E Contrast Media Mol Imaging; 2014; 9(4):291-9. PubMed ID: 24706613 [TBL] [Abstract][Full Text] [Related]
10. In vitro measurement of cell death with the annexin A5 affinity assay. van Genderen H; Kenis H; Lux P; Ungeth L; Maassen C; Deckers N; Narula J; Hofstra L; Reutelingsperger C Nat Protoc; 2006; 1(1):363-7. PubMed ID: 17406257 [TBL] [Abstract][Full Text] [Related]
11. Annexin A5: shifting from a diagnostic towards a therapeutic realm. Kenis H; Hofstra L; Reutelingsperger CP Cell Mol Life Sci; 2007 Nov; 64(22):2859-62. PubMed ID: 17876516 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells. Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628 [TBL] [Abstract][Full Text] [Related]
13. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques. van Tilborg GA; Vucic E; Strijkers GJ; Cormode DP; Mani V; Skajaa T; Reutelingsperger CP; Fayad ZA; Mulder WJ; Nicolay K Bioconjug Chem; 2010 Oct; 21(10):1794-803. PubMed ID: 20804153 [TBL] [Abstract][Full Text] [Related]
15. Annexin A5: an imaging biomarker of cardiovascular risk. Laufer EM; Reutelingsperger CP; Narula J; Hofstra L Basic Res Cardiol; 2008 Mar; 103(2):95-104. PubMed ID: 18324365 [TBL] [Abstract][Full Text] [Related]
16. From phage display to magnetophage, a new tool for magnetic resonance molecular imaging. Segers J; Laumonier C; Burtea C; Laurent S; Elst LV; Muller RN Bioconjug Chem; 2007; 18(4):1251-8. PubMed ID: 17521160 [TBL] [Abstract][Full Text] [Related]
17. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Schellenberger EA; Bogdanov A; Högemann D; Tait J; Weissleder R; Josephson L Mol Imaging; 2002; 1(2):102-7. PubMed ID: 12920851 [TBL] [Abstract][Full Text] [Related]
18. Transmembrane voltage regulates binding of annexin V and lactadherin to cells with exposed phosphatidylserine. Smith C; Gibson DF; Tait JF BMC Biochem; 2009 Feb; 10():5. PubMed ID: 19222854 [TBL] [Abstract][Full Text] [Related]
19. Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V/propidium iodide assay. Lecoeur H; Prévost MC; Gougeon ML Cytometry; 2001 May; 44(1):65-72. PubMed ID: 11309810 [TBL] [Abstract][Full Text] [Related]
20. Domain IV of Annexin A5 Is Critical for Binding Calcium and Guarantees Its Maximum Binding to the Phosphatidylserine Membrane. Wang J; Liu J; Cao Y; Hu M; Hua Z Molecules; 2017 Dec; 22(12):. PubMed ID: 29257055 [No Abstract] [Full Text] [Related] [Next] [New Search]